Clinical trial
RLS In Adults: Comparing Immediate Release Formulation With Extended Release…
NCT00314860 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00314860 |
|---|---|
| Title | RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole |
| Official title | A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS) |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Restless Legs Syndrome, Restless Legs Syndrome (RLS) |
| Intervention type | Drug |
| Interventions | ropinirole Extended Release (XR) |
| Enrollment | 568 |
| Start date | Feb 1, 2006 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Apr 17, 2006 |
| Last update posted | Oct 18, 2016 |
| Countries | Australia, Austria, Belgium, Denmark, France, Germany, Italy, Netherlands, Norway, Spain, Sweden, United Kingdom and 1 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: